Y. Chen et al. / Journal of Organometallic Chemistry 693 (2008) 750–762
759
4.2. Preparation of ligands
NMR (75 MHz, CDCl3, TMS): d 166.5, 155.5, 150.3,
150.0, 146.4, 143.7, 137.7, 135.8 (2C), 134.6, 126.7, 123.8,
123.2 (2C), 122.9, 122.4, 121.4, 120.7, 113.1, 49.1, 28.5
(2C), 23.3 (2C), 22.9 (2C), 21.6 (2C), 17.4. IR (KBr;
cmꢁ1): 2960, 2868, 1650 (mC@N), 1588, 1570, 1454, 1398,
824, 782, 750. Anal. Calc. for C29H34N4 (438.6): C, 79.41;
H, 7.81; N, 12.77. Found: C, 79.37; H, 7.91; N, 12.48%.
4.2.1. Preparation of (E)-N-(1-(6-(1-isopropyl-1H-
benzo[d]imidazol-2-yl)pyridin-2-yl)ethylidene)-2,6-
dimethylbenzenamine (L1)
2-(1-Isopropyl-2-benzimidazolyl)-6-acetylpyridine (167
mg, 0.6 mmol) and 2,6-dimethylaniline (72.7 mg, 0.6 mmol)
were refluxed in toluene (20 ml) in the presence of p-tolu-
enesulfonic. After solvent evaporation, the crude product
was purified by column chromatography on silica gel with
petroleum ether/ethyl acetate (5/1 v/v) as eluent to afford
the product as a yellow powder in 65% yield. M.p.: 143–
145 °C. 1H NMR (300 MHz, CDCl3, TMS): d 8.47 (d,
1H, J = 7.9 Hz, Py), 8.38 (d, 1H, J = 7.7 Hz, Py), 7.99 (t,
1H, J = 7.9, 7.7, Py), 7.87 (m, 1H, Ph), 7.70 (m, 1H, Ph),
7.33 (m, 2H, Ph), 7.09 (d, 2H, J = 7.5 Hz, Ph), 6.96 (t,
1H, J = 6.9, 7.2 Hz, Ph), 6.06 (m, 1H, CH), 2.20 (s, 3H,
CH3), 2.06 (s, 6H, CH3), 1.75 (d, 6H, J = 6.9 Hz, CH3).
13C NMR (75 MHz, CDCl3, TMS): d 165.2, 154.0, 148.9,
148.6, 147.3, 142.3, 136.3 (2C), 133.25, 126.7 (2C), 125.5,
124.1, 121.9, 121.6, 121.0, 119.9, 119.4, 111.7, 47.7, 20.2
(2C), 16.7 (2C), 15.3. IR (KBr; cmꢁ1): 2972, 2937, 1654
(mC@N), 1589, 1570, 1455, 1398, 1207, 825, 754. Anal. Calc.
for C25H26N4 (382.5): C, 78.50; H, 6.85; N, 14.65. Found:
C, 78.32; H, 6.98; N, 14.76%.
4.2.4. (E)-2,6-Difluoro-N-(1-(6-(1-isopropyl-1H-
benzo[d]imidazol-2-yl)pyri-dine-2-yl)ethylidene)-
benzenamine (L4)
Using the same procedure as for the synthesis of L1, L4
was obtained as a yellow powder in 51% yield. M.p.: 94–
1
95 °C. H NMR (300 MHz, CDCl3, TMS):d 8.48 (d, 1H,
J = 7.9 Hz, Py), 8.39 (d, 1H, J = 7.8 Hz, Py), 7.99 (t, 1H,
J = 7.9, 7.8, Py), 7.88 (m, 1H, Ph), 7.71 (m, 1H, Ph), 7.33
(m, 2H, Ph), 7.08 (m, 2H, Ph), 6.99 (m, 2H, Ph), 6.05 (m,
1H, CH), 2.43 (s, 3H, CH3), 1.75 (d, 6H, J = 6.9 Hz,
CH3). 13C NMR (75 MHz, CDCl3, TMS): d 171.9, 154.7,
151.4, 149.9, 149.8, 143.5, 137.7 (2C), 134.5, 127.2 (2C),
124.3, 122.9, 122.3, 121.9, 120.6, 113.0, 111.8, 111.5, 49.0,
21.4 (2C), 17.7. IR (KBr; cmꢁ1): 2969, 1643 (mC@N), 1588,
1453, 824, 745. Anal. Calc. for C23H20F2N4 (390.4): C,
70.75; H, 5.16; N, 14.35. Found: C, 70.80; H, 5.17; N,
14.41%.
4.2.2. (E)-2,6-Diethyl-N-(1-(6-(1-isopropyl-1H-
benzo[d]imidazol-2-yl)-pyridin-2-
yl)ethylidene)benzenamine (L2)
4.2.5. (E)-2,6-Dichloro-N-(1-(6-(1-isopropyl-1H-
benzo[d]imidazol-2-yl)pyridin-2-yl)ethylidene)-
benzenamine (L5)
Using the same procedure as for the synthesis of L1, L2
was obtained as a yellow powder in 79% yield. M.p.: 130–
132 °C. 1H NMR (300 MHz, CDCl3, TMS): d 8.45 (d, 1H,
J = 7.9 Hz, Py), 8.38 (d, 1H, J = 7.8 Hz, Py), 7.99 (t, 1H,
J = 7.9, 7.8 Hz, Py), 7.85 (m, 1H, Ph), 7.61 (m, 1H, Ph),
7.32 (m, 2H, Ph), 7.28 (d, 2H, J = 7.1 Hz, Ph), 7.07(m,
1H, Ph), 6.10 (m, 1H, CH), 2.40 (m, 4H, CH2), 2.22 (s,
3H, CH3), 1.75 (d, 6H, J = 6.0 Hz, CH3) 1.15 (t, 6H,
J = 7.5, 7.5 Hz, CH3). 13C NMR (75 MHz, CDCl3,
TMS): d 165.0, 154.1, 148.6, 148.5, 146.4, 142.3, 136.3,
133.3, 129.9 (2C), 125.4, 124.7 (2C), 122.2, 121.6, 120.9,
119.9, 119.4, 111.7, 47.7, 23.4 (2C), 20.2 (2C), 15.7, 12.4
(2C). IR (KBr; cmꢁ1): 2970, 2934, 1654 (mC@N), 1587,
1568, 1455, 1397, 1384, 827, 748. Anal. Calc. for
C27H30N4 (410.6): C, 78.99; H, 7.37; N, 13.65. Found: C,
78.74; H, 7.31; N, 13.44%.
2-(1-Isopropyl-2-benzimidazolyl)-6-acetylpyridine (279
mg, 1 mmol) and 2,6-dichlorolaniline (324 mg, 2 mmol)
were refluxed in ethyl silicate (4 ml) in the presence of p-tol-
uenesulfonic. After solvent evaporation, the crude product
was purified by column chromatography on alumina with
petroleum ether/ethyl acetate (10/1 v/v) as eluent to afford
the product as a yellow powder in 5% yield. M.p.: 121–
122 °C. 1H NMR (300 MHz, CDCl3, TMS): d 8.47 (d,
1H, J = 7.4 Hz, Py), 8.41 (d, 1H, J = 7.4 Hz, Py), 8.00 (t,
1H, J = 7.4, 7.4, Py), 7.86 (m, 1H, Ph), 7.70 (m, 1H, Ph),
7.37 (d, 2H, J = 7.9, 7.9 Hz, Ph), 7.30 (m, 2H, Ph), 7.01
(t, 1H, J = 8.3, 7.9 Hz, Ph), 6.04 (m, 1H, CH), 2.33 (s,
3H, CH3), 1.75 (d, 6H, J = 6.9 Hz, CH3). 13C NMR
(75 MHz, CDCl3, TMS): d 170.8, 155.2, 154.6, 150.1,
145.6, 143.6, 137.9 (2C), 134.6, 128.4 (2C), 127.4, 124.7,
124.6, 123.0, 122.4, 122.1, 120.7, 113.1, 49.1, 21.6 (2C),
17.8. IR (KBr; cmꢁ1): 2970, 1658 (mC@N), 1588, 1455,
1434, 1399, 824, 789, 744. Anal. Calc. for C23H20Cl2N4
(423.3): C, 65.25; H, 4.76; N, 13.23. Found: C, 64.93; H,
4.90; N, 12.94%.
4.2.3. (E)-2,6-Diisopropyl-N-(1-(6-(1-isopropyl-1H-
benzo[d]imidazol-2-yl)pyridin-2-
yl)ethylidene)benzenamine (L3)
Using the same procedure as for the synthesis of L1, L3
was obtained as a yellow powder in 80% yield. M.p.: 179–
180 °C. 1H NMR (300 MHz, CDCl3, TMS): d 8.44 (d, 1H,
J = 7.9 Hz, Py), 8.38 (d, 1H, J = 7.3 Hz, Py), 7.99 (t, 1H,
J = 7.9, 7.3 Hz, Py), 7.73 (m, 1H, Ph), 7.62 (m, 1H, Ph),
7.32 (m, 2H, Ph), 7.18 (m, 2H, Ph), 7.14 (m, 1H, Ph),
6.07 (m, 1H, CH), 2.76 (m, 2 H, CH), 1.75 (d, 6H,
J = 7.0 Hz, CH3), 1.16 (d, 12H, J = 6.8 Hz, CH3). 13C
4.2.6. (E)-2,4,6-Trimethyl-N-(1-(6-(1-isopropyl-1H-
benzo[d]imidazol-2-yl)pyridin-2-yl)ethylidene)-
benzenamine (L6)
Using the same procedure as for the synthesis of L1, L6
was obtained as a yellow powder in 71% yield. M.p.: 189–
190 °C. 1H NMR (400 MHz, CDCl3, TMS): d 8.49 (d, 1H,
J = 8.0 Hz, Py), 8.37 (d, 1H, J = 7.8 Hz, Py), 8.00 (t, 1H,